메뉴 건너뛰기




Volumn 25, Issue 10, 2015, Pages 749-753

Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test

(38)  Pane, Marika a   Fanelli, Lavinia a   Mazzone, Elena Stacy a   Olivieri, Giorgia a   D'Amico, Adele b   Messina, Sonia c   Scutifero, Marianna d   Battini, Roberta e   Petillo, Roberta d   Frosini, Silvia e   Sivo, Serena a   Vita, Gian Luca c   Bruno, Claudio f   Mongini, Tiziana g   Pegoraro, Elena h   De Sanctis, Roberto a   Gardani, Alice i   Berardinelli, Angela i   Lanzillotta, Valentina f   Carlesi, Adelina b   more..


Author keywords

Duchenne muscular dystrophy; Glucocorticoids; Non ambulant; PUL; Upper limb

Indexed keywords

GLUCOCORTICOID;

EID: 84941737689     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2015.07.009     Document Type: Article
Times cited : (46)

References (14)
  • 1
    • 84879551615 scopus 로고    scopus 로고
    • The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures
    • Henricson E.K., Abresch R.T., Cnaan A., et al. The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures. Muscle Nerve 2013, 48:55-67. 10.1002/mus.23808.
    • (2013) Muscle Nerve , vol.48 , pp. 55-67
    • Henricson, E.K.1    Abresch, R.T.2    Cnaan, A.3
  • 2
    • 84865550123 scopus 로고    scopus 로고
    • Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
    • Bushby K., Connor E. Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clin Investig (London) 2011, 1:1217-1235. 10.4155/cli.11.113.
    • (2011) Clin Investig (London) , vol.1 , pp. 1217-1235
    • Bushby, K.1    Connor, E.2
  • 3
    • 84919859690 scopus 로고    scopus 로고
    • Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy
    • Lynn S., Aartsma-Rus A., Bushby K., et al. Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy. Neuromuscul Disord 2015, 25:96-105.
    • (2015) Neuromuscul Disord , vol.25 , pp. 96-105
    • Lynn, S.1    Aartsma-Rus, A.2    Bushby, K.3
  • 4
    • 76549130473 scopus 로고    scopus 로고
    • Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
    • Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010, 9:177-189. 10.1016/S1474-4422(09)70272-8.
    • (2010) Lancet Neurol , vol.9 , pp. 177-189
    • Bushby, K.1    Finkel, R.2    Birnkrant, D.J.3
  • 5
    • 72149108443 scopus 로고    scopus 로고
    • Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
    • Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010, 9:77-93. 10.1016/S1474-4422(09)70271-6.
    • (2010) Lancet Neurol , vol.9 , pp. 77-93
    • Bushby, K.1    Finkel, R.2    Birnkrant, D.J.3
  • 6
    • 41749096186 scopus 로고    scopus 로고
    • Glucocorticoid corticosteroids for Duchenne muscular dystrophy
    • Published Online First
    • Manzur A.Y., Kuntzer T., Pike M., Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2008, Published Online First. 10.1002/14651858.CD003725.
    • (2008) Cochrane Database Syst Rev
    • Manzur, A.Y.1    Kuntzer, T.2    Pike, M.3    Swan, A.4
  • 7
    • 84877594408 scopus 로고    scopus 로고
    • Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy
    • Ricotti V., Ridout D.A., Scott E., et al. Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 2013, 84:698-705.
    • (2013) J Neurol Neurosurg Psychiatry , vol.84 , pp. 698-705
    • Ricotti, V.1    Ridout, D.A.2    Scott, E.3
  • 8
    • 73349127499 scopus 로고    scopus 로고
    • Diagnosis and new treatments in muscular dystrophies
    • Manzur A.Y., Muntoni F. Diagnosis and new treatments in muscular dystrophies. Postgrad Med J 2009, 85:622-630.
    • (2009) Postgrad Med J , vol.85 , pp. 622-630
    • Manzur, A.Y.1    Muntoni, F.2
  • 9
    • 84860896654 scopus 로고    scopus 로고
    • Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up
    • Merlini L., Gennari M., Malaspina E., et al. Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up. Muscle Nerve 2012, 45:796-802.
    • (2012) Muscle Nerve , vol.45 , pp. 796-802
    • Merlini, L.1    Gennari, M.2    Malaspina, E.3
  • 10
    • 84866424753 scopus 로고    scopus 로고
    • A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy
    • Mazzone E.S., Vasco G., Palermo C., et al. A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy. Dev Med Child Neurol 2012, 54:879-885.
    • (2012) Dev Med Child Neurol , vol.54 , pp. 879-885
    • Mazzone, E.S.1    Vasco, G.2    Palermo, C.3
  • 11
    • 84894248468 scopus 로고    scopus 로고
    • Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy
    • Pane M., Mazzone E.S., Fanelli L., et al. Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. Neuromuscul Disord 2014, 24:201-206.
    • (2014) Neuromuscul Disord , vol.24 , pp. 201-206
    • Pane, M.1    Mazzone, E.S.2    Fanelli, L.3
  • 12
    • 84885175848 scopus 로고    scopus 로고
    • Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy
    • Mayhew A., Mazzone E.S., Eagle M., et al. Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy. Dev Med Child Neurol 2013, 55:1038-1045.
    • (2013) Dev Med Child Neurol , vol.55 , pp. 1038-1045
    • Mayhew, A.1    Mazzone, E.S.2    Eagle, M.3
  • 13
    • 84875444308 scopus 로고    scopus 로고
    • All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in duchenne muscular dystrophy
    • Schram G., Fournier A., Leduc H., et al. All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in duchenne muscular dystrophy. J Am Coll Cardiol 2013, 61:948-954. 10.1016/j.jacc.2012.12.008.
    • (2013) J Am Coll Cardiol , vol.61 , pp. 948-954
    • Schram, G.1    Fournier, A.2    Leduc, H.3
  • 14
    • 84925350947 scopus 로고    scopus 로고
    • Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy
    • Connolly A.M., Malkus E.C., Mendell J.R., et al. Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy. Muscle Nerve 2015, 51:522-532.
    • (2015) Muscle Nerve , vol.51 , pp. 522-532
    • Connolly, A.M.1    Malkus, E.C.2    Mendell, J.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.